14542-71-3 Usage
Uses
Used in Organic Synthesis:
2,6-DIBROMO-4-METHOXYTOLUENE, 98+% is used as a key intermediate for organic synthesis, facilitating the creation of a broad spectrum of chemical compounds due to its reactive bromine and methoxy substituents.
Used in Pharmaceutical Production:
In the pharmaceutical industry, 2,6-DIBROMO-4-METHOXYTOLUENE, 98+% is utilized as an intermediate in the synthesis of various drugs, contributing to the development of new medicinal agents.
Used in Agrochemical Manufacturing:
2,6-DIBROMO-4-METHOXYTOLUENE, 98+% is employed as a crucial component in the production of agrochemicals, playing a role in the formulation of effective pesticides and other agricultural products.
Used in Specialty Chemicals Industry:
2,6-DIBROMO-4-METHOXYTOLUENE, 98+% is also used as an intermediate for the production of specialty chemicals, where its unique structure and high purity are advantageous for creating high-quality end products.
Check Digit Verification of cas no
The CAS Registry Mumber 14542-71-3 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 1,4,5,4 and 2 respectively; the second part has 2 digits, 7 and 1 respectively.
Calculate Digit Verification of CAS Registry Number 14542-71:
(7*1)+(6*4)+(5*5)+(4*4)+(3*2)+(2*7)+(1*1)=93
93 % 10 = 3
So 14542-71-3 is a valid CAS Registry Number.
InChI:InChI=1/C8H8Br2O/c1-5-7(9)3-6(11-2)4-8(5)10/h3-4H,1-2H3
14542-71-3Relevant academic research and scientific papers
ISOINDOLONE COMPOUNDS AS HPK1 INHIBITORS
-
Page/Page column 46, (2021/11/13)
This invention relates to compounds of general Formula I and pharmaceutically acceptable salts thereof, in which R1, R2, R2a, R3, R4, (R5)a and X are as defined herein, to pharmaceutical compositions comprising such compounds and salts, and to methods of using such compounds, salts and compositions for the treatment of abnormal cell growth, including cancer.
INHIBITORS OF P38 MITOGEN-ACTIVATED PROTEIN KINASE
-
Page/Page column 22, (2008/12/05)
Compounds of formula (I) are inhibitors of p38 MAP kinase activity, and are useful in the treatment of, inter alia, inflammatory and autoimmune disease formula (I): wherein R3, R4, R5 and R6 are each independently hydrogen or halogen; M and P are independently -N= or -CH=; Z is (a) a radical of formula R1R2CHNH-Y-L1-X1-(CH2)Z-, wherein R1R2CHNH- is an N-linked amino acid or amino acid ester group as defined in the description, and -Y-L1-X1-(CH2)Z- is a linker radical as defined in the description.